X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (17243) 17243
Book Chapter (187) 187
Magazine Article (91) 91
Newsletter (71) 71
Newspaper Article (49) 49
Publication (9) 9
Dissertation (7) 7
Book / eBook (6) 6
Web Resource (6) 6
Conference Proceeding (4) 4
Reference (3) 3
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15321) 15321
science & technology (10147) 10147
life sciences & biomedicine (9839) 9839
female (7975) 7975
male (7265) 7265
heparin - adverse effects (6886) 6886
middle aged (5553) 5553
aged (4838) 4838
heparin - therapeutic use (4815) 4815
heparin (4701) 4701
anticoagulants - adverse effects (4617) 4617
anticoagulants - therapeutic use (4133) 4133
adult (3886) 3886
cardiovascular system & cardiology (3443) 3443
heparin - administration & dosage (3360) 3360
abridged index medicus (3200) 3200
thrombocytopenia - chemically induced (3116) 3116
anticoagulants - administration & dosage (2567) 2567
anticoagulants (2438) 2438
treatment outcome (2340) 2340
risk factors (2288) 2288
hematology (2226) 2226
heparin, low-molecular-weight - therapeutic use (2008) 2008
peripheral vascular disease (2002) 2002
cardiac & cardiovascular systems (1989) 1989
heparin, low-molecular-weight - adverse effects (1720) 1720
hemorrhage - chemically induced (1705) 1705
animals (1630) 1630
surgery (1606) 1606
general & internal medicine (1473) 1473
thrombosis (1464) 1464
time factors (1452) 1452
aged, 80 and over (1429) 1429
retrospective studies (1322) 1322
prospective studies (1311) 1311
pregnancy (1205) 1205
heparin, low-molecular-weight - administration & dosage (1101) 1101
fibrinolytic agents - therapeutic use (1099) 1099
medicine, general & internal (1088) 1088
thrombosis - prevention & control (1069) 1069
thromboembolism (1041) 1041
thromboembolism - prevention & control (1021) 1021
thrombocytopenia (986) 986
heparin - pharmacology (971) 971
thrombosis - etiology (936) 936
adolescent (893) 893
postoperative complications - prevention & control (876) 876
drug therapy (849) 849
fibrinolytic agents - adverse effects (845) 845
drug therapy, combination (800) 800
thrombocytopenia - diagnosis (785) 785
pharmacology & pharmacy (782) 782
heparin-induced thrombocytopenia (779) 779
care and treatment (775) 775
medicine & public health (763) 763
glycosaminoglycans (744) 744
dose-response relationship, drug (743) 743
warfarin - therapeutic use (733) 733
anticoagulation (699) 699
health aspects (696) 696
venous thrombosis - prevention & control (676) 676
recombinant proteins - therapeutic use (675) 675
blood coagulation - drug effects (673) 673
analysis (666) 666
thrombosis - drug therapy (658) 658
follow-up studies (653) 653
risk assessment (645) 645
aspirin - therapeutic use (624) 624
incidence (619) 619
platelet aggregation inhibitors - therapeutic use (610) 610
venous thromboembolism (608) 608
respiratory system (607) 607
randomized controlled trials as topic (606) 606
venous thrombosis - drug therapy (604) 604
platelet count (601) 601
thrombocytopenia - drug therapy (600) 600
pulmonary embolism - drug therapy (597) 597
child (593) 593
recurrence (575) 575
myocardial infarction - drug therapy (568) 568
venous thromboembolism - prevention & control (566) 566
drug administration schedule (565) 565
pulmonary embolism (557) 557
low-molecular-weight heparin (551) 551
warfarin - adverse effects (550) 550
injections, subcutaneous (544) 544
bleeding (537) 537
patients (537) 537
anticoagulants - pharmacology (535) 535
research (522) 522
pulmonary embolism - prevention & control (520) 520
warfarin (520) 520
fibrinolytic agents - administration & dosage (519) 519
heparin - immunology (518) 518
thrombocytopenia - immunology (514) 514
double-blind method (507) 507
cardiology (497) 497
low molecular weight heparin (493) 493
acute disease (488) 488
cardiopulmonary bypass (486) 486
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (6) 6
Gerstein Science - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Pharmacy (1) 1
Credit Valley Hospital - Closed Orders (1) 1
Scarborough Hospital - General (1) 1
Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15738) 15738
German (735) 735
French (637) 637
Spanish (209) 209
Japanese (182) 182
Russian (117) 117
Italian (110) 110
Chinese (58) 58
Polish (44) 44
Portuguese (32) 32
Dutch (26) 26
Swedish (26) 26
Czech (24) 24
Danish (24) 24
Hungarian (24) 24
Norwegian (22) 22
Croatian (11) 11
Romanian (11) 11
Turkish (11) 11
Serbian (8) 8
Finnish (7) 7
Hebrew (7) 7
Korean (4) 4
Afrikaans (3) 3
Slovak (3) 3
Bulgarian (2) 2
Bosnian (1) 1
Lithuanian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation (New York, N.Y.), ISSN 1524-4539, 02/2014, Volume 129, Issue 7, pp. 764 - 772
Dabigatran and warfarin have been compared for the treatment of acute venous thromboembolism (VTE) in a previous trial. We undertook this study to extend those... 
Antagonists & inhibitors | Recurrence | Thrombin | Warfarin | Hemorrhage | Venous thromboembolism | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Anticoagulants - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Warfarin - adverse effects | Male | Antithrombins - administration & dosage | Dabigatran | Heparin - adverse effects | Warfarin - administration & dosage | Venous Thromboembolism - drug therapy | Young Adult | Benzimidazoles - administration & dosage | Adult | Female | Benzimidazoles - adverse effects | Venous Thromboembolism - epidemiology | beta-Alanine - analogs & derivatives | Acute Disease | beta-Alanine - adverse effects | Double-Blind Method | Hemorrhage - epidemiology | Risk Factors | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Antithrombins - adverse effects | Adolescent | Aged | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage | Usage | Care and treatment | Dabigatran etexilate | Thromboembolism | Index Medicus | Abridged Index Medicus | Anticoagulants | Benzimidazoles | Heparin, Low-Molecular-Weight | Life Sciences | Venous Thromboembolism | Antithrombins | Heparin | beta-Alanine
Journal Article
Critical care medicine, ISSN 0090-3493, 06/2010, Volume 38 Suppl, Identification and Prevention of Common Adverse Drug Events in the Intensive Care Unit, Issue 6, pp. S198 - S218
Journal Article
The New England journal of medicine, ISSN 1533-4406, 05/2008, Volume 358, Issue 21, pp. 2218 - 2230
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2011, Volume 58, Issue 22, pp. 2263 - 2269
Chronic kidney disease (CKD) is prevalent and affects an ever-increasing proportion of patients presenting with acute coronary syndrome (ACS). Patients with... 
Cardiovascular | Internal Medicine | non–ST-segment elevation myocardial infarction | chronic kidney disease | bleeding | ST-segment elevation myocardial infarction | unstable angina | acute coronary syndrome(s) | antiplatelet | antithrombotic | nonST-segment elevation myocardial infarction | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Piperazines - administration & dosage | Prasugrel Hydrochloride | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Heparin - administration & dosage | Thiophenes - administration & dosage | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Aspirin - administration & dosage | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Acute Coronary Syndrome - complications | Aspirin - adverse effects | Adenosine - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Polysaccharides - administration & dosage | Kidney Diseases - complications | Platelet Aggregation Inhibitors - adverse effects | Peptide Fragments - administration & dosage | Polysaccharides - adverse effects | Clinical Trials as Topic | Uremia - complications | Adenosine - administration & dosage | Piperazines - adverse effects | Recombinant Proteins - administration & dosage | Ticlopidine - analogs & derivatives | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Acute Coronary Syndrome - drug therapy | Adenosine - analogs & derivatives | Hirudins - adverse effects | Fibrinolytic Agents - administration & dosage | Peptide Fragments - adverse effects | Hemorrhage - chemically induced | Chronic Disease | Care and treatment | Chronic kidney failure | Cardiac patients | Cardiology | Coronary heart disease | Health aspects | Cardiovascular agents | Medical colleges | Mortality | Heart attacks | Drug therapy | Acute coronary syndromes | Coronary vessels | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2011, Volume 365, Issue 21, pp. 1980 - 1989
Journal Article
The New England journal of medicine, ISSN 1533-4406, 06/2008, Volume 358, Issue 23, pp. 2457 - 2467
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e24S - e43S
.... Heparin also binds to cells and plasma proteins other than antithrombin causing unpredictable pharmacokinetic and pharmacodynamic properties and triggering nonhemorrhagic side effects... 
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Heparitin Sulfate - adverse effects | United States | Humans | Thrombin - antagonists & inhibitors | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Dose-Response Relationship, Drug | Pipecolic Acids - administration & dosage | Chondroitin Sulfates - adverse effects | Societies, Medical | Pipecolic Acids - adverse effects | Heparitin Sulfate - administration & dosage | Polysaccharides - administration & dosage | Thrombosis - blood | Thrombosis - prevention & control | Dermatan Sulfate - administration & dosage | Dermatan Sulfate - adverse effects | Peptide Fragments - administration & dosage | Polysaccharides - adverse effects | Evidence-Based Medicine | Recombinant Proteins - administration & dosage | Antithrombins - agonists | Chondroitin Sulfates - administration & dosage | Hirudins - adverse effects | Fibrinolytic Agents - administration & dosage | Peptide Fragments - adverse effects | Thrombosis - drug therapy | Heparin, Low-Molecular-Weight - administration & dosage | Infusions, Intravenous | Practice Guidelines as Topic | Index Medicus | Abridged Index Medicus | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article